These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 37842592)
1. Prognostic value and immune infiltration of ARMC10 in pancreatic adenocarcinoma via integrated bioinformatics analyses. Li TH; Qin XH; Wang LQ; Qin C; Zhao BB; Cao HT; Yang XY; Wang YY; Li ZR; Zhou XT; Wang WB Heliyon; 2023 Oct; 9(10):e20464. PubMed ID: 37842592 [TBL] [Abstract][Full Text] [Related]
2. Transmembrane Protein 170B is a Prognostic Biomarker and Associated With Immune Infiltrates in Pancreatic Adenocarcinoma. Zhang Z; Shang J; Dai Z; Yao Y; Shi Y; Zhong D; Liang Y; Lai C; Yang Q; Feng T; Huang X Front Genet; 2022; 13():848391. PubMed ID: 35601487 [No Abstract] [Full Text] [Related]
3. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma. Yan C; Niu Y; Li F; Zhao W; Ma L J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146 [TBL] [Abstract][Full Text] [Related]
4. PLAGL1 is associated with prognosis and cell proliferation in pancreatic adenocarcinoma. Liang X; Fu Z; Tang L; Zheng M; Chen D; Liu A; Shi L; Yang L; Shao C; Dong X BMC Gastroenterol; 2023 Jan; 23(1):2. PubMed ID: 36600208 [TBL] [Abstract][Full Text] [Related]
5. A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma. Chen Y; Lin X; Zou X; Qian Y; Liu Y; Wang R; Wang X; Yu X; Liu C; Cheng H BMC Gastroenterol; 2023 Apr; 23(1):113. PubMed ID: 37024802 [TBL] [Abstract][Full Text] [Related]
6. High WFDC3 gene expression is associated with poor prognosis and reduced immune cells infiltration in pancreatic adenocarcinoma: A study using the TCGA database and bioinformatics analysis. Wu W; Wang J; Hu Z; Zhao Y; Wang X; Bai N; Chen L; Gao P Medicine (Baltimore); 2023 Oct; 102(42):e35595. PubMed ID: 37861515 [TBL] [Abstract][Full Text] [Related]
7. Deoxythymidylate kinase (DTYMK) participates in cell cycle arrest to promote pancreatic adenocarcinoma progression regulated by miR-491-5p through TP53 and is associated with tumor immune infiltration. Bao W; Yang H; Zhou S; Huang F; Wei Z; Peng Z J Gastrointest Oncol; 2023 Jun; 14(3):1546-1559. PubMed ID: 37435228 [TBL] [Abstract][Full Text] [Related]
8. Phospholipase A/acyltransferase 4 is a prognostic biomarker and correlated with immune infiltrates in pancreatic cancer. Li TH; Wang YY; Zhao BB; Qin C; Li ZR; Wang WB Heliyon; 2022 Sep; 8(9):e10416. PubMed ID: 36091946 [TBL] [Abstract][Full Text] [Related]
9. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma. Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324 [TBL] [Abstract][Full Text] [Related]
10. Identification of Prognostic Immune-Related Genes in Pancreatic Adenocarcinoma and Establishment of a Prognostic Nomogram: A Bioinformatic Study. Wu G; Deng Z; Jin Z; Wang J; Xu B; Zeng J; Peng M; Wen Z; Guo Y Biomed Res Int; 2020; 2020():1346045. PubMed ID: 32596278 [TBL] [Abstract][Full Text] [Related]
11. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer. Wu M; Li X; Zhang T; Liu Z; Zhao Y Front Oncol; 2019; 9():996. PubMed ID: 31612115 [No Abstract] [Full Text] [Related]
12. A novel cuproptosis-related gene model predicts outcomes and treatment responses in pancreatic adenocarcinoma. Liu Q; Li R; Wu H; Liang Z BMC Cancer; 2023 Mar; 23(1):226. PubMed ID: 36894917 [TBL] [Abstract][Full Text] [Related]
13. KRT7 Overexpression is Associated with Poor Prognosis and Immune Cell Infiltration in Patients with Pancreatic Adenocarcinoma. Li Y; Su Z; Wei B; Liang Z Int J Gen Med; 2021; 14():2677-2694. PubMed ID: 34188523 [TBL] [Abstract][Full Text] [Related]
14. Identification of a Four Cancer Stem Cell-Related Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Adenocarcinoma. Li S; Chen R; Luo W; Lin J; Chen Y; Wang Z; Lin W; Li B; Wang J; Yang J Comb Chem High Throughput Screen; 2022; 25(12):2070-2081. PubMed ID: 35048799 [TBL] [Abstract][Full Text] [Related]
15. A four oxidative stress gene prognostic model and integrated immunity-analysis in pancreatic adenocarcinoma. Wang H; Tian RF; Liang X; Fan J; Duan ZC; Fan XY; Zhang JJ; Yao DS; Chen ZN; Li L Front Oncol; 2022; 12():1015042. PubMed ID: 36713541 [TBL] [Abstract][Full Text] [Related]
16. Expression, oncological and immunological characterizations of BZW1/2 in pancreatic adenocarcinoma. Ge J; Mu S; Xiao E; Tian G; Tao L; Li D Front Genet; 2022; 13():1002673. PubMed ID: 36267402 [No Abstract] [Full Text] [Related]
17. Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P Front Immunol; 2022; 13():805311. PubMed ID: 35154122 [TBL] [Abstract][Full Text] [Related]
18. Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma. Xue S; Ge W; Wang K; Mao T; Zhang X; Xu H; Wang Y; Yao J; Li S; Yue M; Ma J; Wang Y; Shentu D; Cui J; Wang L Front Cell Dev Biol; 2022; 10():942225. PubMed ID: 36003146 [TBL] [Abstract][Full Text] [Related]
19. Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma. Li TH; Qin C; Zhao BB; Cao HT; Yang XY; Wang YY; Li ZR; Zhou XT; Wang WB Front Oncol; 2021; 11():665192. PubMed ID: 34123827 [TBL] [Abstract][Full Text] [Related]
20. Analysis and validation of the potential of the MYO1E gene in pancreatic adenocarcinoma based on a bioinformatics approach. Liu S; Liu P; Fei X; Zhu C; Hou J; Wang X; Pan Y Oncol Lett; 2023 Jul; 26(1):285. PubMed ID: 37274465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]